Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
Department of Women's and Children's Health, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Transl Psychiatry. 2022 May 5;12(1):186. doi: 10.1038/s41398-022-01954-6.
Children of mothers with prenatal depressive symptoms (PND) have a higher risk of behavioral problems; fetal programming through DNA methylation is a possible underlying mechanism. This study investigated DNA methylation in cord blood to identify possible "at birth" signatures that may indicate susceptibility to behavioral problems at 18 months of age. Cord blood was collected from 256 children of mothers who had self-reported on symptoms of depression during pregnancy and the behavior of their child at 18 months of age. Whole genome DNA methylation was assessed using Illumina MethylationEPIC assay. The mother and child pairs were categorized into four groups, based on both self-reported depressive symptoms, PND or Healthy control (HC), and scores from the Child Behavior checklist (high or low for internalizing, externalizing, and total scores). Adjustments were made for batch effects, cell-type, and clinical covariates. Differentially methylated sites were identified using Kruskal-Wallis test, and Benjamini-Hochberg adjusted p values < 0.05 were considered significant. The analysis was also stratified by sex of the child. Among boys, we observed higher and correlated DNA methylation of one CpG-site in the promoter region of TPP1 in the HC group, with high externalizing scores compared to HC with low externalizing scores. Boys in the PND group showed lower DNA methylation in NUDT15 among those with high, compared to low, internalizing scores; the DNA methylation levels of CpGs in this gene were positively correlated with the CBCL scores. Hence, the differentially methylated CpG sites could be of interest for resilience, regardless of maternal mental health during pregnancy. The findings are in a relatively healthy study cohort, thus limiting the possibility of detecting strong effects associated with behavioral difficulties. This is the first investigation of cord blood DNA methylation signs of fetal programming of PND on child behavior at 18 months of age and thus calls for independent replications.
患有产前抑郁症状(PND)母亲的孩子患行为问题的风险更高;通过 DNA 甲基化进行胎儿编程是一种可能的潜在机制。本研究通过检测脐带血中的 DNA 甲基化来鉴定可能的“出生时”特征,这些特征可能表明 18 个月大时易患行为问题。研究人员从 256 名自我报告孕期抑郁症状的母亲及其 18 个月大的孩子中采集了脐带血。使用 Illumina MethylationEPIC 检测试剂盒评估全基因组 DNA 甲基化。根据母亲的自我报告抑郁症状、PND 或健康对照组(HC)以及儿童行为检查表(内化、外化和总分高或低),将母婴对子分为四组。对批次效应、细胞类型和临床协变量进行了调整。使用 Kruskal-Wallis 检验鉴定差异甲基化位点,Benjamini-Hochberg 调整的 p 值<0.05 被认为具有统计学意义。还按孩子的性别对分析进行了分层。在男孩中,我们观察到 HC 组中 TPP1 启动子区域一个 CpG 位点的 DNA 甲基化水平较高,且与 HC 组中高外化评分的男孩相比,其与高外化评分呈正相关。PND 组的男孩与低内化评分相比,其 NUDT15 中 DNA 甲基化水平较低;该基因的 CpG 甲基化水平与 CBCL 评分呈正相关。因此,无论母亲在孕期的心理健康状况如何,差异甲基化的 CpG 位点都可能与适应力有关。这些发现是在一个相对健康的研究队列中得出的,因此限制了检测与行为困难相关的强效应的可能性。这是首次调查 PND 对 18 个月大儿童行为的胎儿编程对脐带血 DNA 甲基化的影响,因此需要独立复制。